Authors


Annie Eisenbeis, PharmD, MBA

Latest:

The Perfect Ingredient: Vaccine Education With Pharmacy Community Health Workers

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.


Mark Mulvahill, MBA, MSc

Latest:

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.


Amruta Chowgule

Latest:

Regional Trends Reinforcing Breast Cancer Therapeutics Market

Over the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.


David Gortler, PharmD, FCCP

Latest:

How the White House's New FDA Commissioner Caused the Baby Formula Crisis

The FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.


Christopher Epps, PharmD Candidate

Latest:

Case Studies: June 2022

How would you respond to these patients questions?


Lauren Stonerock, PharmD

Latest:

As Easy as ABE: A Pharmacist’s Overview of Updates to the COPD GOLD Guidelines

Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.


Sarvenaz Atighetchi, PharmD Candidate

Latest:

Understand the Use of Panzyga for Immune-Related Disorders

Pharmacists should educate patients about their treatment regimen and potential adverse effects.



Sawyer Y. Mustopoh

Latest:

The Ethics and Economics of California’s End of Life Option Act

In addition to moral arguments, economic issues must be considered.


Alyssa Christensen, PharmD, BCIDP

Latest:

Implementing CDC’s Core Elements of Sepsis

The agency outlines key elements for building effective hospital sepsis programs.


Husna Rahim, PharmD, RPh

Latest:

Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment

BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.


Herman W. Powery II, PharmD, BCOP

Latest:

Current Drug Pathways in Non–Small Cell Lung Cancer

Advancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.


Christian Gee

Latest:

Five Fast Facts About IVIG

By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.


Bani Tamraz, PharmD, PhD

Latest:

How 2023 Can Be the Year of Clinical Pharmacogenomics

In terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.


Nabila Ismail, PharmD

Latest:

Dengue Vaccine: What Pharmacists Need to Know

The FDA approved the first vaccine for dengue disease in May 2019.


Syuleyman Bektashev

Latest:

Interactive Case Studies: January 2022

How would you respond to these patients' questions?


Bob Zutaut, RPh

Latest:

Offering Specialty Infusions May Be Worth the Work for Oncology Practices

Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.


Mindy Smith, BSPharm, RPh, MHA, CMWA

Latest:

Driving Patient Safety With New Pharmacy HIT Standards

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.


Carissa Treptow, PharmD, BCOP

Latest:

Multiple Myeloma Therapy Often Causes Cardiovascular Complications

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.


Chloe Siu, PharmD, BCPS, BCOP

Latest:

Emerging Bispecific T-Cell Engagers in Myeloma: Promises and Hurdles

The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.


Vicki Keedy, MD

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Rachel Marini, PharmD

Latest:

Recognize the Value of Health Care Volunteers

The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.


Advit Shah, BSc, BSc Pharmacy, RPh

Latest:

How to Create an Inclusive Culture for LGBTQ+ Patients at the Pharmacy: A Practical Approach

Facilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.


Kasey Jackson, PharmD, BCOP

Latest:

The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.


Cameron Abbey-Mott, PharmD

Latest:

Clinical Overview: Dapagliflozin for Patients with Heart Failure, Reduced Ejection Fraction and Preserved Ejection Fraction

Management of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.


Carl V. Crawford, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


John B. Buse, MD, PhD

Latest:

Semaglutide and Cardiovascular Risk Reduction: What the Latest Data Tell Us

John Buse, MD, PhD discusses the expanding role of GLP-1 receptor agonists in treatment of cardiovascular conditions.


Nishant Thakar, PharmD; Ibraheem Rajab, Bchem; and Sinni Moozhayil, BPharm, MS

Latest:

Extemporaneous Compounding of Amoxicillin Suspensions During National Shortage

As of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.


Nithya Srinivasan, Director of Marketing, Rheumatology, Janssen Immunology

Latest:

Holistic Psoriatic Arthritis Care: Why Well-Being Should Be Incorporated Into the Treatment Paradigm

People living with psoriatic arthritis deserve to be informed about ways to approach disease management holistically and with a personalized approach.


Doug Field

Latest:

Pharmacies Poised to Capture At-Home Diagnostics Category

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.